Result: There were no drug resistant mutations (lamivudine-resistant pattern:
rtM204V/I,
rtL180M,
rtV173L, adefovir-resistant pattern:
rtA181V/T, tenofovir-resistant pattern:
rtA194T and entecavir-resistant pattern:
rtL180M,
rtS202G,
rtM204V) detectable in acute patients belonging to our study population.